All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Terminal Sedation | NCIT_C21115 | [The purposeful use of morphine, other opiates, or other pharmaceuticals at doses adequate to end life functions.] |
| Palliative Therapy | NCIT_C15292 | [The patient- and family-centered active holistic care of patients with advanced, progressive disease. Essential components of palliative care are: pain and symptom control, communication regarding treatment and alternatives, prognosis, and available services, rehabilitation services, care that addresses treatment and palliative concerns, intellectual, emotional, social, and spiritual needs, terminal care, support in bereavement. The goal of palliative care is an achievement of the best quality of life for patients and their families.] |
| Absence of Invasion of the Muscularis Externa | NCIT_C60723 | |
| Absence of Muscle Invasion | NCIT_C61108 | |
| Terminal Illness | NCIT_C21116 | [An illness that has a prognosis of death.] |
| Retired Concept 2004 | NCIT_C83480 | |
| Laser Fluorescence | NCIT_C60724 | [A method used to aid in the detection of tooth decay by measuring fluorescence using a laser.] |
| Dental Procedure | NCIT_C38052 | [Any of the dental diagnostic, preventive, and restorative services provided to meet the needs of a patient.] |
| Visual Analog Pain Scale | NCIT_C21120 | [A pain scale marked off like a ruler from 0 to 10 on which the patient marks the current level of pain experienced.] |
| CD40 Gene | NCIT_C21121 | [This gene is involved in the regulation of apoptosis, inflammatory responses, and immune responses.] |
| TNF Receptor Family Gene | NCIT_C21165 | [Human TNF Receptor Family Genes encode transmembrane receptor proteins regulated by TNF Family ligands. TNF receptors typically contain intracellular death domains involved in the formation of a signal transducing death-inducing complex that includes FADD and caspases that trigger an apoptotic caspase cascade. Some TNF receptors can activate NF-Kappa-B, MAPK3/ERK1, MAPK8/JNK, BIRC1, BIRC2, BAG4/SODD, TRADD, or TRAF2 and transduce inflammation or anti-apoptotic proliferating signals. Some TNF Family Receptors act as competitive decoy receptors in bone resorption or suppress FasL- and LIGHT-mediated cell death. (NCI)] |
| B-Cell Differentiation | NCIT_C28391 | [In mammalian bone marrow, B-Cell Development consists of progressive differentiation from CD34+ progenitor cells to plasma and memory B cells by positive/negative selection in response to local signals, including antigens and cytokines. B cell development begins with immunoglobulin gene somatic recombination and pre-B cell receptor expression. Antigen-induced signal transduction via BCR-associated ITAM molecules activates B cell proliferation. Further differentiation involves additional immunoglobulin gene recombination and expression. Antigen-stimulated circulating (resting) B cells proliferate and differentiate into plasma and memory B cell clones expressing immunoglobulins with the same antigen recognition site.] |
| WHO Analgesic Method | NCIT_C21122 | [Developed to promote the sequential use of drugs to achieve effective pain relief. The first step is a non-opioid medication (such as aspirin, paracetamol, or ibuprofen). If this does not relieve the pain, an opioid for mild to moderate pain (such as codeine) should be added. When an opioid for mild to moderate pain in combination with a non-opioid medication does not provide effective analgesia, then an opioid for moderate to severe pain (such as morphine or one in the therapeutic group of morphine) should be substituted. Adjuvant drugs should be given at any point during drug treatment to relieve adverse effects of analgesics, to enhance pain relief, and to treat concomitant psychological disturbances such as insomnia, anxiety, and depression. (WHO)] |
| Individualized | NCIT_C60729 | [Made for or directed or adjusted to a particular individual.] |
| Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7 | NCIT_C35758 | [Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)] |
| Lung Large Cell Carcinoma by AJCC v7 Stage | NCIT_C136493 | [A term that refers to the staging of large cell lung carcinoma, following the rules of the TNM AJCC v7 classification system.] |
| Stage 0 Lung Non-Small Cell Cancer AJCC v6 and v7 | NCIT_C9104 | [Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)] |
| Metastasizing Pleomorphic Adenoma of the Salivary Gland | NCIT_C35759 | [A very rare pleomorphic adenoma of the salivary glands that metastasizes inexplicably, despite the benign histopathologic features. The most common sites of metastasis are bone, lung, and head and neck.] |
| Metastatic Benign Neoplasm | NCIT_C36264 | |
| Tracheal Atresia | NCIT_C35754 | [A rare, fatal congenital malformation in which the trachea is severely underdeveloped.] |